The regulation and function of the NUAK family

Journal of Molecular Endocrinology

Volumn 51, Issue 2, 2013, Pages

  Sun, Xianglan ^a   Gao, Ling ^a   Chien, Hung Yu ^b   Li, Wan Chun ^b,c   Zhao, Jiajun ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

AMP activated protein kinase (AMPK); AMPK related kinase; ARK5; LKB1; NUAK family; Sucrose non fermenting protein kinase (SNF1) AMPKrelated kinase (SNARK)

Indexed keywords

AMP ACTIVATED PROTEIN KINASE REGULATED KINASE NOVEL (NUA) KINASE FAMILY; AMP ACTIVATED PROTEIN KINASE REGULATED KINASE NOVEL (NUA) KINASE FAMILY 1; AMP ACTIVATED PROTEIN KINASE REGULATED KINASE NOVEL (NUA) KINASE FAMILY 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; UNCLASSIFIED DRUG;

ENZYME REGULATION; ENZYME STRUCTURE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW;

AMP-ACTIVATED PROTEIN KINASE (AMPK); AMPK-RELATED KINASE; ARK5; LKB1; NUAK FAMILY; SUCROSE-NON-FERMENTING PROTEIN KINASE (SNF1)/AMPK-RELATED KINASE (SNARK);

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; HUMANS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES;

EID: 84884622688     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-13-0063     Document Type: Review

References (52)

1. Al-Hakim A.K., Zagorska A, Chapman L, Deak M, Peggie M & Alessi DR 2008 Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains. Biochemical Journal 411 249-260. (doi:10.1042/BJ20080067)
2. Bright N.J., Thornton C & Carling D 2009 The regulation and function of mammalian AMPK-related kinases. Acta Physiologica 196 15-26. (doi:10.1111/j.1748-1716.2009.01971.x)
3. Carling D & Hardie DG 1989 The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase. Biochimica et Biophysica Acta 1012 81-86. (doi:10.1016/0167-4889(89)90014-1)
4. Chang H.W., Lee YS, Nam HY, Han MW, Kim HJ, Moon SY, Jeon H, Park JJ, Carey T.E., Chang SE, Kim SW & Kim SY 2013 Knockdown of β-catenin controls both apoptotic and autophagic cell death through LKB1/AMPK signaling in head and neck squamous cell carcinoma cell lines. Cell Signaling 25 839-847. (doi:10.1016/j.cellsig.2012.12.020)
5. Chen P., Li K, Liang Y, Li L & Zhu X 2013 High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasion. Experimental Lung Research 39 9-17. (doi:10.3109/01902148. 2012.744115)
6. Drewes G., Ebneth A, Preuss U, Mandelkow EM & Mandelkow E 1997 MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell 89 297-308. (doi:10.1016/S0092-8674(00)80208)
7. Egan B & Zierath JR 2009 Hunting for the SNARK in metabolic disease. American Journal of Physiology. Endocrinology and Metabolism 296 E969-E972. (doi:10.1152/ajpendo.00178.2009)
8. Fisher J.S., Ju JS, Oppelt PJ, Smith JL, Suzuki A & Esumi H 2005 Muscle contractions, AICAR, and insulin cause phosphorylation of an AMPK-related kinase. American Journal of Physiology. Endocrinology and Metabolism 289 E986-E992. (doi:10.1152/ajpendo.00335.2004)
9. Hardie D.G., Carling D & Carlson M 1998 The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annual Review of Biochemistry 67 821-855. (doi:10.1146/annurev.biochem.67. 1.821)
10. Hashimoto K., Kato K, Imamura K, Kishimoto A, Yoshikawa H, Taketani Y & Esumi H 2002 5-Amino-4-imidazolecarboxamide riboside confers strong tolerance to glucose starvation in a 5-AMP-activated protein kinase-dependent fashion. Biochemical and Biophysical Research Communications 290 263-267. (doi:10.1006/bbrc.2001.6193)
11. Hawley S.A., Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR & Hardie DG 2003 Complexes between the LKB1 tumor suppressor, STRAD α/β and MO25 α/β are upstream kinases in the AMP-activated protein kinase cascade. Journal of Biological Chemistry 2 28. (doi:10.1186/1475-4924-2-28)
12. Hawley S.A., Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG & Hardie DG 2005 Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metabolism 2 9-19. (doi:10.1016/j.cmet.2005.05.009)
13. Hemminki A., Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G., Warren W, AminoffM& Höglund P 1998 A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391 184-187. (doi:10.1038/34432)
14. Hou C.H., Chiang YC, Fong YC & Tang CH 2011 WISP-1 increases MMP-2 expression and cell motility in human chondrosarcoma cells. Biochemical Pharmacology 81 1286-1295. (doi:10.1016/j.bcp.2011.03. 016)
15. Humbert N., Navaratnam N, Augert A, Da Costa M, Martien S, Wang J, Martinez D., Abbadie C, Carling D, de Launoit Y et al. 2010 Regulation of ploidy and senescence by the AMPK-related kinase NUAK1. EMBO Journal 29 376-386. (doi:10.1038/emboj.2009.342)
16. Ichinoseki-Sekine N, Naito H, Tsuchihara K, Kobayashi I, Ogura Y, Kakigi R, Kurosaka M., Fujioka R& Esumi H 2009 Provision of a voluntary exercise environment enhances running activity and prevents obesity in Snark-deficient mice. American Journal of Physiology. Endocrinology and Metabolism 296 E1013-E1021. (doi:10.1152/ajpendo.90891.2008)
17. Inazuka F., Sugiyama N, Tomita M, Abe T, Shioi G & Esumi H 2012 Musclespecific knock-out of NUAK family SNF1-like kinase 1 (NUAK1) prevents high fat diet-induced glucose intolerance. Journal of Biological Chemistry 287 16379-16389. (doi:10.1074/jbc.M111.302687)
18. Ito M., Nakano T, Erdodi F & Hartshorne DJ 2004 Myosin phosphatase: structure, regulation and function. Molecular and Cellular Biochemistry 259 197-209. (doi:10.1023/B:MCBI.0000021373.14288.00)
19. Jaleel M., Villa F, Deak M, Toth R, Prescott AR, Van Aalten DM & Alessi DR 2006 The ubiquitin-associated domain of AMPK-related kinases regulates conformation and LKB1-mediated phosphorylation and activation. Biochemical Journal 394 545-555. (doi:10.1042/BJ20051844)
20. Kahn B.B., Alquier T, Carling D & Hardie DG 2005 AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metabolism 1 15-25. (doi:10.1016/j.cmet.2004. 12.003)
21. Kato K., Ogura T, Kishimoto A, Minegishi Y, Nakajima N, Miyazaki M & Esumi H 2002 Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene 21 6082-6090. (doi:10.1038/sj.onc.1205737)
22. Kim J.H., Kim WS & Park C 2008 SNARK, a novel downstream molecule of EBV latent membrane protein 1, is associated with resistance to cancer cell death. Leukemia & Lymphoma 49 1392-1398. (doi:10.1080/ 10428190802087454)
23. Kishi M., Pan YA, Crump JG & Sanes JR 2005 Mammalian SAD kinases are required for neuronal polarization. Science 307 929-932. (doi:10.1126/ science.1107403)
24. Koh H.J., Toyoda T, Fujii N, Jung MM, Rathod A, Middelbeek RJ, Lessard SJ, Treebak J.T., Tsuchihara K, Esumi H et al. 2010 Sucrose nonfermenting AMPK-related kinase (SNARK) mediates contraction-stimulated glucose transport in mouse skeletal muscle. PNAS 107 15541-15546. (doi:10. 1073/pnas.1008131107)
25. Kuga W., Tsuchihara K, Ogura T, Kanehara S, Saito M, Suzuki A & Esumi H 2008 Nuclear localization of SNARK; its impact on gene expression. Biochemical and Biophysical Research Communications 377 1062-1066. (doi:10.1016/j.bbrc.2008.10.143)
26. Kusakai G., Suzuki A, Ogura T, Kaminishi M & Esumi H 2004a Strong association of ARK5 with tumor invasion and metastasis. Journal of Experimental & Clinical Cancer Research 23 263-268.
27. Kusakai G., Suzuki A, Ogura T, Miyamoto S, Ochiai A, Kaminishi M & Esumi H 2004b ARK5 expression in colorectal cancer and its implications for tumor progression. American Journal of Pathology 164 987-995. (doi:10.1016/S0002-9440(10)63186-0)
28. Lefebvre DL & Rosen CF 2005 Regulation of SNARK activity in response to cellular stresses. Biochimica et Biophysica Acta 1724 71-85. (doi:10.1016/ j.bbagen.2005.03.015)
29. Lefebvre D.L., Bai Y, Shahmolky N, Sharma M, Poon R, Drucker DJ & Rosen CF 2001 Identification and characterization of a novel sucrosenon-fermenting protein kinase/AMP-activated protein kinase-related protein kinase, SNARK. Biochemical Journal 355 297-305. (doi:10.1042/ 0264-6021:3550297)
30. Legembre P., Schickel R, Barnhart BC & Peter ME 2004 Identification of SNF1/AMP kinase-related kinase as an NF-κB-regulated anti-apoptotic kinase involved in CD95-induced motility and invasiveness. Journal of Biological Chemistry 279 46742-46747. (doi:10.1074/jbc. M404334200)
31. Liu L., Ulbrich J, Müller J, Wüstefeld T, Aeberhard L, Kress TR, Muthalagu N, Rycak L., Rudalska R, Moll R, Kempa S, Zender L, Eilers M & Murphy DJ 2012 Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature 483 608-612. (doi:10.1038/ nature10927)
32. Lizcano J.M., Goransson O, Toth R, Deak M, Morrice NA, Boudeau J, Hawley SA, Udd L, Makela TP, Hardie DG et al. 2004 LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO Journal 23 833-843. (doi:10.1038/sj.emboj.7600110)
33. Mitchelhill K.I., Stapleton D, Gao G, House C, Michell B, Katsis F, Witters LA & Kemp BE 1994 Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase. Journal of Biological Chemistry 269 2361-2364.
34. Momcilovic M., Hong SP & Carlson M 2006 Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. Journal of Biological Chemistry 281 25336-25343. (doi:10.1074/jbc.M604399200)
35. Niesler C.U., Myburgh KH & Moore F 2007 The changing AMPK expression profile in differentiating mouse skeletal muscle myoblast cells helps confer increasing resistance to apoptosis. Experimental Physiology 92 207-217. (doi:10.1113/expphysiol.2006.034736)
36. Roh S.A., Choi EY, Cho DH, Jang SJ, Kim SY, Kim YS & Kim JC 2010 Growth and invasion of sporadic colorectal adenocarcinomas in terms of genetic change. Journal of Korean Medical Science 25 353-360. (doi:10.3346/jkms.2010.25.3.353)
37. Rosen C.F., Poon R & Drucker DJ 1995 UVB radiation-activated genes induced by transcriptional and posttranscriptional mechanisms in rat keratinocytes. American Journal of Physiology 268 C846-C855.
38. Rune A., Osler ME, Fritz T & Zierath JR 2009 Regulation of skeletal muscle sucrose, non-fermenting 1/AMP-activated protein kinase-related kinase (SNARK) by metabolic stress and diabetes. Diabetologia 52 2182-2189. (doi:10.1007/s00125-009-1465-x)
39. Shorning BY & Clarke A 2011 LKB1 loss of function studied in vivo. FEBS Letters 585 958-966. (doi:10.1016/j.febslet.2011.01.019)
40. Stein S.C., Woods A, Jones NA, DavisonMD & Carling D 2000 The regulation of AMP-activated protein kinase by phosphorylation. Biochemical Journal 345 437-443. (doi:10.1042/0264-6021:3450437)
41. Suzuki A., Kusakai G, Kishimoto A, Lu J, Ogura T & Esumi H 2003a ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation. Oncogene 22 6177-6182. (doi:10.1038/sj.onc.1206899)
42. Suzuki A., Kusakai G, Kishimoto A, Lu J, Ogura T, Lavin MF & Esumi H 2003b Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein. Journal of Biological Chemistry 278 48-53. (doi:10.1074/jbc.M206025200)
43. Suzuki A., Kusakai G, Kishimoto A, Minegichi Y, Ogura T & Esumi H 2003c Induction of cell-cell detachment during glucose starvation through F-actin conversion by SNARK, the fourth member of the AMP-activated protein kinase catalytic subunit family. Biochemical and Biophysical Research Communications 311 156-161. (doi:10.1016/j.bbrc. 2003.09.184)
44. Suzuki A., Lu J, Kusakai G, Kishimoto A, Ogura T & Esumi H 2004 ARK5 is a tumor invasion-associated factor downstream of Akt signaling. Molecular and Cellular Biology 24 3526-3535. (doi:10.1128/MCB.24.8. 3526-3535.2004)
45. Suzuki A., Iida S, Kato-Uranishi M, Tajima E, Zhan F, Hanamura I, Huang Y, Ogura T., Takahashi S, Ueda R et al. 2005 ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma. Oncogene 24 6936-6944. (doi:10.1038/sj.onc.1208844)
46. Suzuki A., Ogura T & Esumi H 2006 NDR2 acts as the upstream kinase of ARK5 during insulin-like growth factor-1 signaling. Journal of Biological Chemistry 281 13915-13921. (doi:10.1074/jbc.M511354200)
47. Tsuchihara K., Ogura T, Fujioka R, Fujii S, Kuga W, Saito M, Ochiya T, Ochiai A & Esumi H 2008 Susceptibility of Snark-deficient mice to azoxymethane-induced colorectal tumorigenesis and the formation of aberrant crypt foci. Cancer Science 99 677-682. (doi:10.1111/j.1349-7006.2008.00734.x)
48. Wang J.W., Imai Y & Lu B 2007 Activation of PAR-1 kinase and stimulation of tau phosphorylation by diverse signals require the tumor suppressor protein LKB1. Journal of Neuroscience 27 574-581.
49. Williams T & Brenman JE 2008 LKB1 and AMPK in cell polarity and division. Trends in Cell Biology 18 193-198. (doi:10.1016/j.tcb.2008. 01.008)
50. 2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metabolism 2 21-33. (doi:10.1016/j.cmet.2005. 06.005)
51. Xing M 2007 BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocrine Reviews 28 742-762. (doi:10.1210/er.2007-0007)
52. Yamamoto H., Takashima S, Shintani Y, Yamazaki S, Seguchi O, Nakano A, Higo S., Kato H, Liao Y, Asano Y et al. 2008 Identification of a novel substrate for TNFα-induced kinase NUAK2. Biochemical and Biophysical Research Communications 365 541-547. (doi:10.1016/j.bbrc.2007. 11.013)